{"ticker": {"uuid": "4012b281-5472-4ac4-a82d-4c8db1f645d5", "symbol": "DRREDDY", "name": "Dr. Reddy's Laboratories Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPQXlYVG1xODZaNEhwZzlQd2ZDWnRnbHZDTXRueTB6UU1OR1pzS1RjV2ZIM0JYeTVWb2I5WlJZVXF1VEczd0VCZEZGaVQ5U04xOHRGMEVTUkpGRjJtYmt3aml2RFNhSVdaZ0xGdVUwNDVldmlMNTlHSG9WOXkzb3Rpdlh1UXFYN2JtZGl0WG9sSlAxWmNxVTNJMnZyU0pLQlV6MEJyZUc4Zm0tcnJ5eGJRdGtuazFLc2F3ekdTZWVQcXpqcmktSl9IalAxb2ppOVRB?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T21:02:01+00:00", "published_display": "12 Jul 2026 21:02", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy\u2019s Laboratories (NYSE: RDY) shares link to July 9, 2026 conference call audio", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNcWRPd3VrNk5MTnZjM0duUUZNSXBTRXktQ0V5dkdXc09FOFFDMjdPLUc1eDFhRTJkTlppR2ljaFNwdHU0ZTJtNWI1Sm45TFRCZjNKWkpMNHlHdVN3Q3BMZDdMaFNiOW5WNEc5akhaMDF6WEZRUmk0TFl2TVpUUHlacXU2WjBYS2Y4WnUwMWlncTc4VTFFREdTSXFFQ3FBX0pkMUlDd2VnVURmQnhJMFktUEtBM0VoRkVfLTI5ajl3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T10:21:10+00:00", "published_display": "10 Jul 2026 10:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Dr Reddy\u2019s Laboratories stock sliding today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQLWZ5bGQzOEUteDh4WlROREJQeV81MHQzeXFEZXF6eml4NXh3ZVZHNjUtZXZJYU04WDRVcDRiMC1SM3VzMEFfandIaWZXOTl3dzNxcGROVFBhdmRKSllfZ2VsLVg5ZFBIZ0o4WEhyaS1GblpqY1d5TU1lWWpwNUk0azNxd3NaRnh2WnlrOGhWS3ZQMUxIR1huNkVtcFFOdXFFQXFxN242U3Q2VnowLWlwZg?oc=5", "source_name": "Investing.com", "published_at": "2026-07-09T08:15:26+00:00", "published_display": "09 Jul 2026 08:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy's Laboratories shares fall 6% on semaglutide batch concerns, supply delay", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNZnJsXzc3WjBjY2hDZXllZjdMNkhFYlR3NjgtbGtOXzJNOTNnWjVoOV9kZi1LdXdjYkgxRGVBMjNRY0ZoV0RkeWVvRjkwdE9iRFdGd0VUbVVGYmtIajJEdUFjYm14ME1idzd5V20wSEgtMlQ0R2IyM3k5ajJfNm00OVRoU0M0SWttamNBQWRnMy1EVXdoV2YzSzVydTNFRFMwSUdkajRnb29iOGFHbHJySFRnSU9ucDZkWW9SMVAzWjQ5cEpWbGhEZzJJN2RWMHdIS3FVT9IB2gFBVV95cUxPOVA1d3ozTnc3ZmxfYnBBejRCUXllV0Y3Uy01bEJZX0lia0FYNl9MeW5XTWdLOVJmUDhXWWh0dG9lNnZjbi1hdDBqX2RkX2xQd0dNY3FGNHJSbVZ4MGk0ZDRlWFhZYjBjSU5wcHdtMHJES2NYdVFPTlJlUG4wWjRuVXRKUk44T1VXeWxPenJuekhDZU1VZGM1RVFPSmphRGl2bkJkRDByY202WnBHYzRkYmp2R0NtTkUzTnYxbXJXSmdBNVhOVWUwVjZlZnBvUEdfY2JlTGZHeEMwdw?oc=5", "source_name": "CNBC TV18", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Smart To Buy Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Before It Goes Ex-Dividend?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1DZkgzYUh4amRUNTlncHpySHktVWFjV29yRDV2M1RoalpjNGRlVk5LZVIybGZmQnU5WHlieGV2blBDaU1WX0QyaE9oSTZKckl2eG9wYVdoX3I?oc=5", "source_name": "webull.com", "published_at": "2026-07-07T09:08:05+00:00", "published_display": "07 Jul 2026 09:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Reddy's Laboratories Ltd (RDY) Stock Up 4.7% and Still Underv", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNeEhpdHpIeWVNcHJoUUlDOHdOeDI3dnRRcVh3M2o0X2FuQjNaNEgyUHVxTlpMUEp5SkE3eFJhVGZoUWNFZHdJTDRNcVNLcVdGN2lsaEVzMFExc3U3bTFSWHdkbWFKdkFrU21JNkpTLTg5SnpLTDhuOVFTZzFtUnlNRlNERkpiVkxTbVlkTExlOXk0R2VWRU9YZjR5YzNpb1VvTXROQ2Z1TGZTVW83S256ODFrSWxhbVlMdEZ2YWFXR3VKaGhBUGphaDVB?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy's Laboratories Q4 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOYmdFbFViS1lWdTVoVnpIQWJ2THhoaEZmb1dqazdFalY4bktvRE15ekdmYUdLdTFiMFlHaml1dlNldFJyQXhhbVdDMXctTGVYMUZiaW9jN3dxRW16YTR1bWdDRGowbldNelk5eXhjU3FUdVJjU2swdnRQaGVjZklCdjVwSGd6ZkN6ODJzX1RNYzVRdEhoYjhwaXdCeHBfYV9IcXFUUHA5X3JwbkRYM3cxRml3?oc=5", "source_name": "TradingView", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy's Laboratories Ltd Stock 12\u2011Month Price Target Cut to $13.79, Implies 11% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxOSmtzRWNCRnM3RFlvU2VIejl2ZllIWFJmZEFHR1JRRkZSSTBOSEs0UUhvVFJuSjhmTWNZTTByUVFEU29tbmlOWGJMSHRXNDFBNktMejBBLW1VYnhqdktMdmdjUTJZRnE4enBEQjIta3dPSlNHdHB3a3JGZ0lZQXdvSjFhd2ZNdHJGcE14dVpOeHFHYU9KUnVwM1g5MnpiSWdzMWFzb2JtNGxMN1dENzc5RHMzamdjbkVGWkYyZl9aVHdJQm1ud2F2NzVlbmNuT01BTHJyTEVDV2hSMVp4bFRIbm9B?oc=5", "source_name": "TradingView", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy\u2019s Laboratories (RDY) Announces Rollout of Injectable Semaglutide Under Brand Name Obeda\u00ae", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOTUdIcl93aVJtUU1ZMFJTR0sxbkE5Q2V5Nl9BSmN2SnR4eDVjY0RObDFVY0Z1ME1YbWV2cFZWU1pUdGh2c3NLdVo1eGQ2cC1pcGRLZWFnRWsyVm9CcWxvOVNRS2hSU1Vyems3b3NjWjNRNWUyVHhQbmlXY245MVNXX2xJY2JRMzNMRS1TZDRPdnpub1VGWUduOEdZUEsyM01pTFBWRzA4MA?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) Passes Key Peter Lynch Investment Screen", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPNk9CSUE3NDlVYnhBRlNNd2N4SkpMWlg4akdCbVdzUnVMOXllbE9zX3M0djhQWVFLWU9hOW00RTRjMmJfSHFLSlJEOEZJZU9HdjhfTTBRbzVsN2dTRFhGcndDUWxwei1aMHU0Q2hWRjZBcUNyckFwWUhSRGRpZmtvamJfUWVwTjJ5WERENUdmVi15NkJyZV93TnJvSVA3TktTNG5DTXpCamQ1Q2hKOWhFTWY3THZEQXFsSk9sTy0yOUZ1dnBV?oc=5", "source_name": "ChartMill", "published_at": "2026-03-28T07:00:00+00:00", "published_display": "28 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPQXlYVG1xODZaNEhwZzlQd2ZDWnRnbHZDTXRueTB6UU1OR1pzS1RjV2ZIM0JYeTVWb2I5WlJZVXF1VEczd0VCZEZGaVQ5U04xOHRGMEVTUkpGRjJtYmt3aml2RFNhSVdaZ0xGdVUwNDVldmlMNTlHSG9WOXkzb3Rpdlh1UXFYN2JtZGl0WG9sSlAxWmNxVTNJMnZyU0pLQlV6MEJyZUc4Zm0tcnJ5eGJRdGtuazFLc2F3ekdTZWVQcXpqcmktSl9IalAxb2ppOVRB?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T21:02:01+00:00", "published_display": "12 Jul 2026 21:02", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy\u2019s Laboratories (NYSE: RDY) shares link to July 9, 2026 conference call audio", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNcWRPd3VrNk5MTnZjM0duUUZNSXBTRXktQ0V5dkdXc09FOFFDMjdPLUc1eDFhRTJkTlppR2ljaFNwdHU0ZTJtNWI1Sm45TFRCZjNKWkpMNHlHdVN3Q3BMZDdMaFNiOW5WNEc5akhaMDF6WEZRUmk0TFl2TVpUUHlacXU2WjBYS2Y4WnUwMWlncTc4VTFFREdTSXFFQ3FBX0pkMUlDd2VnVURmQnhJMFktUEtBM0VoRkVfLTI5ajl3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T10:21:10+00:00", "published_display": "10 Jul 2026 10:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Dr Reddy\u2019s Laboratories stock sliding today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQLWZ5bGQzOEUteDh4WlROREJQeV81MHQzeXFEZXF6eml4NXh3ZVZHNjUtZXZJYU04WDRVcDRiMC1SM3VzMEFfandIaWZXOTl3dzNxcGROVFBhdmRKSllfZ2VsLVg5ZFBIZ0o4WEhyaS1GblpqY1d5TU1lWWpwNUk0azNxd3NaRnh2WnlrOGhWS3ZQMUxIR1huNkVtcFFOdXFFQXFxN242U3Q2VnowLWlwZg?oc=5", "source_name": "Investing.com", "published_at": "2026-07-09T08:15:26+00:00", "published_display": "09 Jul 2026 08:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy's Laboratories shares fall 6% on semaglutide batch concerns, supply delay", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-07-09T07:00:00+00:00", "published_display": "09 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Smart To Buy Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Before It Goes Ex-Dividend?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1DZkgzYUh4amRUNTlncHpySHktVWFjV29yRDV2M1RoalpjNGRlVk5LZVIybGZmQnU5WHlieGV2blBDaU1WX0QyaE9oSTZKckl2eG9wYVdoX3I?oc=5", "source_name": "webull.com", "published_at": "2026-07-07T09:08:05+00:00", "published_display": "07 Jul 2026 09:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr Reddy's Laboratories Ltd (RDY) Stock Up 4.7% and Still Underv", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNeEhpdHpIeWVNcHJoUUlDOHdOeDI3dnRRcVh3M2o0X2FuQjNaNEgyUHVxTlpMUEp5SkE3eFJhVGZoUWNFZHdJTDRNcVNLcVdGN2lsaEVzMFExc3U3bTFSWHdkbWFKdkFrU21JNkpTLTg5SnpLTDhuOVFTZzFtUnlNRlNERkpiVkxTbVlkTExlOXk0R2VWRU9YZjR5YzNpb1VvTXROQ2Z1TGZTVW83S256ODFrSWxhbVlMdEZ2YWFXR3VKaGhBUGphaDVB?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy's Laboratories Q4 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOYmdFbFViS1lWdTVoVnpIQWJ2THhoaEZmb1dqazdFalY4bktvRE15ekdmYUdLdTFiMFlHaml1dlNldFJyQXhhbVdDMXctTGVYMUZiaW9jN3dxRW16YTR1bWdDRGowbldNelk5eXhjU3FUdVJjU2swdnRQaGVjZklCdjVwSGd6ZkN6ODJzX1RNYzVRdEhoYjhwaXdCeHBfYV9IcXFUUHA5X3JwbkRYM3cxRml3?oc=5", "source_name": "TradingView", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy's Laboratories Ltd Stock 12\u2011Month Price Target Cut to $13.79, Implies 11% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxOSmtzRWNCRnM3RFlvU2VIejl2ZllIWFJmZEFHR1JRRkZSSTBOSEs0UUhvVFJuSjhmTWNZTTByUVFEU29tbmlOWGJMSHRXNDFBNktMejBBLW1VYnhqdktMdmdjUTJZRnE4enBEQjIta3dPSlNHdHB3a3JGZ0lZQXdvSjFhd2ZNdHJGcE14dVpOeHFHYU9KUnVwM1g5MnpiSWdzMWFzb2JtNGxMN1dENzc5RHMzamdjbkVGWkYyZl9aVHdJQm1ud2F2NzVlbmNuT01BTHJyTEVDV2hSMVp4bFRIbm9B?oc=5", "source_name": "TradingView", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dr. Reddy\u2019s Laboratories (RDY) Announces Rollout of Injectable Semaglutide Under Brand Name Obeda\u00ae", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOTUdIcl93aVJtUU1ZMFJTR0sxbkE5Q2V5Nl9BSmN2SnR4eDVjY0RObDFVY0Z1ME1YbWV2cFZWU1pUdGh2c3NLdVo1eGQ2cC1pcGRLZWFnRWsyVm9CcWxvOVNRS2hSU1Vyems3b3NjWjNRNWUyVHhQbmlXY245MVNXX2xJY2JRMzNMRS1TZDRPdnpub1VGWUduOEdZUEsyM01pTFBWRzA4MA?oc=5", "source_name": "Market source", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DR. REDDY'S LABORATORIES-ADR (NYSE:RDY) Passes Key Peter Lynch Investment Screen", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPNk9CSUE3NDlVYnhBRlNNd2N4SkpMWlg4akdCbVdzUnVMOXllbE9zX3M0djhQWVFLWU9hOW00RTRjMmJfSHFLSlJEOEZJZU9HdjhfTTBRbzVsN2dTRFhGcndDUWxwei1aMHU0Q2hWRjZBcUNyckFwWUhSRGRpZmtvamJfUWVwTjJ5WERENUdmVi15NkJyZV93TnJvSVA3TktTNG5DTXpCamQ1Q2hKOWhFTWY3THZEQXFsSk9sTy0yOUZ1dnBV?oc=5", "source_name": "ChartMill", "published_at": "2026-03-28T07:00:00+00:00", "published_display": "28 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 10, "sentiment_summary": {"positive": 2, "negative": 2, "neutral": 6, "score": 48, "total": 10, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 3.3, "count": 6}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.9, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 1244.3, "latest_week": "2026-07-10", "one_week_move": -8.9, "four_week_move": -1.8, "twelve_week_move": 0.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.249308, "market_dynamics_buy_signal": false, "relative_strength": 0.355897, "fair_value_gap": 1.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 55.0, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-8.9% over one week, -1.8% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 3}, {"label": "Stock Titan", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "CNBC TV18", "count": 1}, {"label": "webull.com", "count": 1}, {"label": "GuruFocus", "count": 1}, {"label": "Market source", "count": 1}, {"label": "ChartMill", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 10}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Regulatory and legal", "count": 1}, {"label": "Macro sensitivity", "count": 1}, {"label": "Earnings", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "10", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-8.9% over one week, -1.8% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk"}], "updated_at": "2026-07-18T00:57:32.803619+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}